Update: The Impact trial is currently running with a commitment to 26,000 participant places in mainland England visit: prepimpacttrial.org.uk to find out more.
The PrEP Impact Trial has been announced to start in September.
Why has it taken so long?
Plans have been delayed for many reasons, including developing the infrastructure for making PrEP available, training medical professionals, and identifying who is eligible to have PrEP in England.
What does this mean?
With NHS England using generic versions of PrEP, Gilead, the manufacturer of Truvada, is under pressure to match the price of generics. With the trial underway, the NHS can look at taking PrEP beyond a trial and creating wider UK access. Wales, Scotland and England are making progress with PrEP, but other parts of the British Isles are likely to progress slower. One strength of having the trial in action means that results can be collected on its effectiveness against HIV, and how cost-effective it is for the NHS. The argument for PrEP on the NHS is much stronger, with figures and results to back it up.
How can I participate in the trial?
If you’d like to participate in the PrEP Impact Trial and are based in mainland England, visit your local GUM clinic from September. If you’re outside mainland England, visit PrEPWatch to see what is happening for you locally, and how to demand PrEP in your area.